Atreca to Present at Upcoming Virtual Investor Conferences
SAN CARLOS, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will present at the following upcoming virtual investor conferences:
HC Wainwright 23rd Annual Global Investment Conference
Baird Global Healthcare Conference
An audio webcast of the HC Wainwright presentation will be available on-demand beginning at 7:00 a.m. Eastern Time on September 13, 2021, and can be accessed through the Events & Presentations section of the Company's website at ir.atreca.com. The presentation will be available on the Company's website for 90 days.
About Atreca, Inc.
Source: Atreca, Inc.
Lunch Vouchers Provided to Paid Conference Pass Holders, Exhibitors, Sponsors, Speakers, Press
AI Everywhere and No Talent to Use It: Building an Equitable Workplace
Digital Transformation Reengineering Process Production